Barclays Initiates Coverage On Zimmer Biomet Holdings with Equal-Weight Rating, Announces Price Target of $100

Benzinga Newsdesk www.benzinga.com Positive 60.4%

Neg 0% Neu 0% Pos 60.4%

Barclays analyst Christopher Pasquale initiates coverage on Zimmer Biomet Holdings (NYSE:ZBH) with a Equal-Weight rating and announces Price Target of $100.